Dr. Yinfeng Yang is a distinguished researcher at Anhui University of Chinese Medicine, known for impactful contributions at the interface of traditional Chinese medicine, molecular pharmacology, and bioinformatics-driven disease mechanism analysis. His academic influence is demonstrated by 5,738 citations, 45 publications, and an h-index of 18, underscoring his growing global recognition in biomedical research. Dr. Yang’s work spans cancer biology, immunometabolism, and natural-product-based therapeutics, with recent studies exploring the clinicopathological relevance of BRCA1 in gastric cancer, mitochondrial pathways in rheumatoid arthritis, and angiogenesis-targeting mechanisms of Ginkgo biloba leaves. His research integrates advanced computational tools, systems pharmacology, and machine learning to decode complex biological networks and accelerate drug discovery particularly in ADMET prediction and precision therapeutic strategies. With more than 120 co-authors and interdisciplinary collaborations across oncology, pharmacology, and traditional medicine, Dr. Yang has built a broad scientific network that strengthens the translational potential of his findings. His publications in high-impact journals and open-access platforms contribute to global knowledge accessibility while supporting evidence-based modernization of traditional Chinese medicine. Dr. Yang’s work carries clear societal relevance, offering novel insights for developing safer, more effective treatments for chronic inflammatory diseases and gastrointestinal cancers. His sustained research output and increasing citation impact position him as a valuable contributor to global biomedical innovation and integrative medicine research.
-
Ru, J., Li, P., Wang, J., Zhou, W., Li, B., Huang, C., Li, P., Guo, Z., Tao, W., Yang, Y., … (2014). TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. Journal of Cheminformatics, 6(1), 13. Cited by: 5,020
-
Qian, S., Wei, Z., Yang, W., Huang, J., Yang, Y., & Wang, J. (2022). The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. Frontiers in Oncology, 12, 985363. Cited by: 876
-
Yang, Y., Li, Y., Wang, J., Sun, K., Tao, W., Wang, Z., Xiao, W., Pan, Y., Zhang, S., … (2017). Systematic investigation of Ginkgo biloba leaves for treating cardio-cerebrovascular diseases in an animal model. ACS Chemical Biology, 12(5), 1363–1372. Cited by: 99
-
Li, Y., Gao, W., Li, F., Wang, J., Zhang, J., Yang, Y., Zhang, S., & Yang, L. (2013). An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine-type CDK2 inhibitors. Molecular BioSystems, 9(9), 2266–2281. Cited by: 53
-
Li, Y., Wang, J., Xiao, Y., Wang, Y., Chen, S., Yang, Y., Lu, A., & Zhang, S. (2015). A systems pharmacology approach to investigate the mechanisms of action of Semen Strychni and Tripterygium wilfordii Hook F for treatment of rheumatoid arthritis. Journal of Ethnopharmacology, 175, 301–314. Cited by: 51